Long Term Follow up of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Teenagers < 18 Years Old with High-Risk Acute Leukemia. Very Good Results in CR1 and CR2 Patients but Unexpected High Incidence of Severe Acute Graft Versus Host Disease in Children < 10 Years
Ángela Maria Trujillo(Instituto de Cancerología Las Américas), Luis Rodolfo Manosalvas Gómez(Amec Foster Wheeler (United States)), Giovanni Ruiz(Instituto de Cancerología Las Américas), Amado Karduss(Instituto de Cancerología Las Américas), Mónica Ramírez(Instituto de Cancerología Las Américas), Gloria Suarez(Instituto de Cancerología Las Américas), Pedro Reyes(Instituto de Cancerología Las Américas), Angélica Cardona(Instituto de Cancerología Las Américas), Rosendo Lurı́a-Pérez(Instituto de Cancerología Las Américas), Jimenez Alejo(Instituto de Cancerología Las Américas), José Betancur(Instituto de Cancerología Las Américas)
Cited by 1
Related Papers
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
|Haematologica|2021|236
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update
|Transplantation and Cellular Therapy|2024|67
Day care and selected employee work behaviors.
|PubMed|1976|62
A multi-gene panel study in hereditary breast and ovarian cancer in Colombia
|Familial Cancer|2017|49